A Multi-Centre, Randomised, Controlled, Masked Phase 2 Study of the Safety and Efficacy of KIO-101 Ophthalmic Solution, Versus Vehicle Control in the Treatment of Dry Eye Disease in Patients With Autoimmune Disease
Clinical trial NCT05629364 · TERMINATED
Trial details
- NCT number
- NCT05629364
- Sponsor
- Kiora Pharmaceuticals, Inc.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-15
- Primary completion
- 2024-01-09
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.